Emami Limited (IN:EMAMILTD)
:EMAMILTD
Top Page
Emami Limited
(EMAMILTD)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹447.00
▼(-15.04% Downside)
Action:ReiteratedDate:11/08/25
Emami Limited's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and profitability margins. However, the technical analysis indicates bearish momentum, which negatively impacts the score. The valuation is reasonable but not particularly attractive. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
High Profit Margins
Sustained high gross and net margins indicate durable pricing power and efficient cost structure in Emami's FMCG portfolio. These margins support long-term cash generation, allow funding for marketing and innovation, and provide a buffer versus input-cost cycles, strengthening profitability resilience.
Negative Factors
Rising Total Liabilities
An uptick in total liabilities, despite low debt, could reflect higher trade payables, provisions or contingent liabilities. If persistent, rising liabilities may pressure working capital, constrain free cash flow, and signal operational or legal risks that could erode financial flexibility over months.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profit Margins
Sustained high gross and net margins indicate durable pricing power and efficient cost structure in Emami's FMCG portfolio. These margins support long-term cash generation, allow funding for marketing and innovation, and provide a buffer versus input-cost cycles, strengthening profitability resilience.
Read all positive factors
Emami Limited (EMAMILTD) vs. iShares MSCI India ETF (INDA)
Market Cap
₹183.27B
Dividend Yield1.91%
Average Volume (3M)27.33K
Price to Earnings (P/E)18.1
Beta (1Y)0.76
Revenue Growth0.84%
EPS Growth-2.44%
CountryIN
Employees3,289
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)7.60
Shares Outstanding439,080,050
10 Day Avg. Volume15,423
30 Day Avg. Volume27,333
Financial Highlights & Ratios
PEG Ratio2.65
Price to Book (P/B)9.26
Price to Sales (P/S)6.55
P/FCF Ratio29.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹589.00Price Target Upside11.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)20.52
Revenue Forecast (FY)₹42.37B
Emami Limited Business Overview & Revenue Model
Company Description
Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, vasocare herbal petroleum jelly, aloe vera gel, and hygiene...
How the Company Makes Money
Emami Limited makes money primarily by manufacturing (directly and/or via third-party/contract manufacturers) and selling branded FMCG products to a network of trade channels (e.g., distributors/stockists, wholesalers, and modern retail), as well ...
Emami Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.15B | 38.09B | 35.78B | 34.06B | 31.87B | 28.81B |
| Gross Profit | 19.24B | 18.89B | 17.32B | 15.00B | 13.59B | 11.82B |
| EBITDA | 9.51B | 10.39B | 9.65B | 8.73B | 9.61B | 8.93B |
| Net Income | 7.54B | 8.06B | 7.24B | 6.40B | 8.39B | 4.55B |
Balance Sheet | ||||||
| Total Assets | 36.71B | 35.34B | 32.80B | 31.10B | 30.57B | 25.20B |
| Cash, Cash Equivalents and Short-Term Investments | 8.90B | 8.26B | 4.09B | 2.99B | 1.83B | 4.46B |
| Total Debt | 719.60M | 897.80M | 939.56M | 905.10M | 2.82B | 1.01B |
| Total Liabilities | 7.42B | 8.40B | 8.22B | 7.97B | 9.83B | 7.58B |
| Stockholders Equity | 29.31B | 26.95B | 24.47B | 23.03B | 20.77B | 17.63B |
Cash Flow | ||||||
| Free Cash Flow | 2.15B | 8.51B | 7.38B | 7.08B | 1.60B | 8.88B |
| Operating Cash Flow | 2.35B | 8.96B | 7.79B | 7.49B | 6.44B | 9.22B |
| Investing Cash Flow | -892.30M | -3.40B | -2.05B | -1.13B | -2.35B | -2.27B |
| Financing Cash Flow | -1.80B | -5.00B | -5.63B | -6.08B | -4.02B | -6.88B |
Emami Limited Technical Analysis
Negative
526.15
Price Trends
456.23
Negative
485.46
Negative
523.61
Negative
Market Momentum
-17.70
Negative
39.37
Neutral
54.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:EMAMILTD, the sentiment is Negative. The current price of 526.15 is above the 20-day moving average (MA) of 414.70, above the 50-day MA of 456.23, and above the 200-day MA of 523.61, indicating a bearish trend. The MACD of -17.70 indicates Negative momentum. The RSI at 39.37 is Neutral, neither overbought nor oversold. The STOCH value of 54.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:EMAMILTD.
Emami Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ₹177.30B | 20.06 | ― | 6.86% | 6.83% | 8.79% | |
68 Neutral | ₹137.60B | 42.68 | ― | 0.26% | 5.73% | -7.74% | |
66 Neutral | ₹154.10B | -90.62 | ― | 0.28% | 14.55% | -20.61% | |
64 Neutral | ₹183.27B | 18.06 | ― | 1.91% | 0.84% | -2.44% | |
64 Neutral | ₹82.57B | 31.99 | ― | 1.24% | 1.62% | -7.32% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ₹158.50B | 41.30 | ― | 1.16% | 0.73% | -5.88% |
* Consumer Defensive Sector Average
IN:EMAMILTD
Emami Limited
417.40
-168.39
-28.75%
IN:CASTROLIND
Castrol India Limited
179.25
-8.32
-4.44%
IN:CROMPTON
Crompton Greaves Consumer Electricals Ltd.
246.15
-79.80
-24.48%
IN:FINEORG
Fine Organic Industries Ltd.
4,487.80
590.49
15.15%
IN:JYOTHYLAB
Jyothy Labs Limited
224.85
-150.91
-40.16%
IN:ZYDUSWELL
Zydus Wellness Limited
484.35
141.23
41.16%
Emami Limited Corporate Events
Emami Withdraws From IIFL Global Investors’ Conference Citing Exigencies
Feb 19, 2026
Emami Limited has notified the stock exchanges that it will not participate in the IIFL 17th Enterprising India Global Investors’ Conference scheduled to be held physically in Mumbai on 25 February 2026. The company cited certain exigencies ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.